Filing search / Innovation Pharmaceuticals Inc. / "Independent"

NT 10-Q

IPIX Innovation Pharmaceuticals Inc.

15 Nov 23

Notice of late quarterly filing

8:00am

in the Registrant’s independent public accounting firm. The Registrant anticipates that it will file the Quarterly Report no later than the fifth calendar

8-K

EX-16.1

IPIX Innovation Pharmaceuticals Inc.

30 Oct 23

Changes in Registrant's Certifying Accountant

4:15pm

and Gentleman: We are the former independent registered public accounting firm for Innovation Pharmaceuticals, Inc. (the “Company”). We have read

8-K

IPIX Innovation Pharmaceuticals Inc.

30 Oct 23

Changes in Registrant's Certifying Accountant

4:15pm

”) as the Company’s independent public accounting firm, a role Pinnacle held since 2018. Also on October 29, 2023, the Audit Committee approved … the engagement of GreenGrowth CPAs (“GreenGrowth”) as the Company’s new independent public accounting firm, and the Company engaged GreenGrowth

8-K

2qln 7m8b

14 Oct 21

Departure of Directors or Certain Officers

5:00pm

8-K

EX-99.1

al5p1ari8kqhi8p5i

15 Jan 21

Innovation Pharmaceuticals’ Brilacidin for the Treatment of COVID-19 Receives

12:35pm

8-K

EX-99.1

emi9p6

22 Dec 20

FDA Grants IND Approval for Phase 2 Clinical Trial of Innovation Pharmaceuticals’ Brilacidin for Treating COVID-19

9:00am